Food Allergy Market Size and Trend Report including Marketed and Pipeline Drug Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030

Pages: 94 Published: April 05, 2022 Report Code: GDHCHT318

The food allergy market was valued at $213.9 million in 2020 globally and is forecast to grow at a CAGR of more than 28% during the forecast period. Food allergy (FA) is defined as an adverse immunologic response to food. While any food can cause an adverse reaction, eight types of food allergens account for the majority of all reactions: eggs, milk, peanuts, tree nuts, fish, shellfish, wheat, and soybeans.

FA is reproducible each time the food is ingested but is often not dose-dependent. It is commonly associated with cutaneous and gastrointestinal reactions. The food allergy market lacks a curative agent, with the only available treatments being antihistamines or epinephrine usage for accidental exposure. The food allergy pipeline consists of 31 drugs across all stages of development, with nine drugs expected to launch by 2030.

Food Allergy Market Overview

Food Allergy Market Overview

For more insights on this report, download a free report sample

What are the key trends in the food allergy market?

Historically, the FA market has seen a lack of R&D. The market was focused on providing symptomatic relief, resulting in the use of off-label drugs such as antihistamines and epinephrine. Additionally, oral immunotherapy (OIT) is the most commonly used treatment to raise the threshold dose for a food allergen and protect allergy patients against accidental ingestion of the allergen.

What are the classifications in the food allergy market?

The classifications in the food allergy market are immunoglobulin E (IgE)-mediated, cell-mediated (non-IgE-mediated), or both IgE- and cell-mediated mechanisms (mixed IgE- and non-IgE-mediated). IgE-mediated allergic responses are the most common type of food allergy, with rapid onset of symptoms after ingestion. In the case of non-IgE-mediated allergic responses, the symptoms are typically delayed for hours, while for mixed IgE- and non-IgE-mediated allergic responses, symptoms appear several hours after the ingestion of the food.

What are the key treatments for food allergy?

The key treatments for food allergy are mild or moderate and severe. In mild or moderate treatment, antihistamines block the effects of histamine, a chemical that is responsible for the majority of allergic reactions. In the severe treatment, epinephrine (adrenaline) constricts the blood vessels to counteract the effects of low blood pressure and relaxes the airways to ease breathing difficulties.

What are the key pipeline products in the food allergy market?

The key pipeline products in the food allergy market are allergy therapeutics for milk allergy, peanut allergy, food allergy, and eosinophilic esophagitis (EoE). The majority of products in development are for peanut allergy, followed by EoE and FA.

Food Allergy Market by Pipeline Products

Food Allergy Market by Pipeline Products

To know more about key pipeline products, download a free report sample

What are the routes of administration in the food allergy market?

The routes of administration in the food allergy market are oral, intravenous, subcutaneous, and intradermal and cutaneous. Oral administration is the most frequently utilized route of administration for products in the FA pipeline.

Food Allergy Market by Routes of Administration

Food Allergy Market by Routes of Administration

To know more about routes of administration, download a free report sample

Who are the key players in the food allergy market?

Some of the key players in the food allergy market are Aimmune Therapeutics, Dr. Falk Pharma GmbH, Sanofi, DBV Technologies SA, Novartis, AstraZeneca, Regeneron Pharmaceuticals Inc, Roche/Genentech, Camallergy (Cambridge Allergy Ltd), ALK-Abello AS, and Ellodi Pharmaceuticals.

Market report scope

Market size (Year – 2020) $213.9 million
Growth rate CAGR of >28%
Forecast period 2020-2030
Classifications Immunoglobulin E (IgE)-Mediated, Cell-Mediated (Non-IgE-Mediated), or Both Ige- and Cell-Mediated Mechanisms (Mixed Ige- and Non-Ige-Mediated)
Key treatments Mild or Moderate and Severe
Key pipeline products Milk Allergy, Peanut Allergy, Food Allergy, and Eosinophilic Esophagitis (EoE)
Routes of administration Oral, Intravenous, Subcutaneous, and Intradermal and Cutaneous
Key players Aimmune Therapeutics, Dr. Falk Pharma GmbH, Sanofi, DBV Technologies SA, Novartis, AstraZeneca, Regeneron Pharmaceuticals Inc, Roche/Genentech, Camallergy (Cambridge Allergy Ltd), ALK-Abello AS, and Ellodi Pharmaceuticals

This report provides:

  • Overview of FA including etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.
  • Key topics including the current treatment and pipeline therapies, trends, clinical trials, unmet needs, challenges and opportunities, and market analysis.
  • Analysis of the current and future market competition in FA therapeutics market.

Reasons to Buy

The report will enable you to:

  • Develop and design your in-licensing and out-licensing strategies, using a detailed overview of current pipeline products and technologies to identify companies with the most robust pipelines.
  • Develop business strategies by understanding the trends shaping and driving the FA therapeutics market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the FA market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track drug sales in the FA therapeutics market from 2020-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Key Players

Aimmune Therapeutics

Dr. Falk Pharma GmbH

Sanofi

DBV Technologies

Novartis

AstraZeneca

Regeneron Pharmaceuticals (Sanofi)

Roche/Genentech

Camallergy (Cambridge Allergy Ltd)

ALK-Abello AS

Ellodi Pharmaceuticals

Table of Contents

Table of Contents (PowerPoint Deck)

1 Executive Summary

1.1 Executive Summary

2 Disease Overview

2.1 Overview of Food Allergy

2.2 Food Allergy Classification

2.3 Treatment Management for IgE-Mediated Food Allergy

2.4 Prognosis of Food Allergy

3 Trends

3.1 Industry Trends

4 Clinical Trials

4.1 Clinical Trials for Food Allergy

4.2 Clinical Trials for Food Allergy by Region

4.3 Food Allergy Clinical Trials by Leading Sponsors

4.4 Clinical Trials for Food Allergy – Challenges

4.5 Clinical Trials for Food Allergy – Opportunities

5 Marketed Products

5.1 IgE-Mediated Products

5.2 Palforzia – Product Profile

5.3 Palforzia – KOL Perspectives

5.4 Palforzia – Strengths and Weaknesses

5.5 Antihistamines – KOL Perspectives

5.6 Antihistamine – Strengths and Weaknesses

5.7 Epinephrine – KOL Perspectives

5.8 Epinephrine – Strengths and Weaknesses

5.9 Oral Immunotherapy – KOL Perspectives

5.10 Oral Immunotherapy – Strengths and Weaknesses

5.11 Nalcrom – Product Profile

6 Pipeline Products

6.1 Pipeline Products by Type and Phase

6.2 Pipeline Products by Therapeutic Class

6.3 Pipeline Products by Route of Administration and Innovation

6.4 Pipeline Drugs: IgE Inhibitors

6.5 Pipeline Drugs: Desensitization Immunotherapy

6.6 Pipeline Drugs: Interleukin Inhibitors

6.7 Pipeline Drugs: Other

7 Market Analysis

7.1 Immunoglobulin E-Mediated Food Allergy Market Analysis and Forecast

7.2 Latest Deals in the Food Allergy Space

7.3 Latest Deals in the Peanut Allergy Space

7.3 Latest Deals in the Eosinophilic Esophagitis Space

8 Opportunities, Challenges, and Unmet Needs

8.1 Global Food Allergy Market – Challenges and Opportunities

8.2 Global Food Allergy Therapeutics Unmet Needs – Gap Analysis

8.3 Impact of COVID-19 on Food Allergy: KOL Perspectives

8 Key Players

9 Appendix

9.1 Bibliography

9.2 Primary Research: KOL Information

9.3 About the Authors

10 Contact Us

Frequently Asked Questions

Request a Free Sample
$6995

Can be used by individual purchaser only

$20985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.